Robert E. Hammer

The University of Texas Southwestern Medical Center — United States

Biochemistry, Genetics and Molecular Biology · Life Sciences

124h-index67.0kcitations365works3.72yr avg
OpenAlex↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Animal Genetics and Reproduction(85), CRISPR and Genetic Engineering(54), Virus-based gene therapy research(33), Cholesterol and Lipid Metabolism(32), Cellular transport and secretion(20)

Publications365 total

Correction: LRP1 integrates murine macrophage cholesterol homeostasis and inflammatory responses in atherosclerosis
eLife·2024· 1 citedOpen Access
Unconventional mechanism of action and resistance to rapalogs in renal cancer
Proceedings of the National Academy of Sciences·2024· 10 citedOpen Access
Chirurgischer Alltag: eine Übersicht über die neue deutsche S3-Leitlinie zur Divertikelkrankheit/Divertikulitis aus chirurgischer Sicht
Journal für Gastroenterologische und Hepatologische Erkrankungen·2024
Target-directed microRNA degradation regulates developmental microRNA expression and embryonic growth in mammals
Genes & Development·2023· 32 citedOpen Access
Target-directed microRNA degradation regulates developmental microRNA expression and embryonic growth in mammals
2023· 7 citedOpen Access
Data from Modeling Renal Cell Carcinoma in Mice: <i>Bap1</i> and <i>Pbrm1</i> Inactivation Drive Tumor Grade
2023Open Access
Supplementary Figure S3 from Modeling Renal Cell Carcinoma in Mice: <i>Bap1</i> and <i>Pbrm1</i> Inactivation Drive Tumor Grade
2023Open Access
Supplementary Figure S1 from Modeling Renal Cell Carcinoma in Mice: <i>Bap1</i> and <i>Pbrm1</i> Inactivation Drive Tumor Grade
2023Open Access
Supplementary Figure Legends from Modeling Renal Cell Carcinoma in Mice: <i>Bap1</i> and <i>Pbrm1</i> Inactivation Drive Tumor Grade
2023Open Access
Data from Modulation of Mutant <i>Kras<sup>G12D</sup></i>-Driven Lung Tumorigenesis <i>In Vivo</i> by Gain or Loss of PCDH7 Function
2023Open Access
Figure S1-S5 from Modulation of Mutant <i>Kras<sup>G12D</sup></i>-Driven Lung Tumorigenesis <i>In Vivo</i> by Gain or Loss of PCDH7 Function
2023Open Access
Supplementary Figure S1 from Modeling Renal Cell Carcinoma in Mice: <i>Bap1</i> and <i>Pbrm1</i> Inactivation Drive Tumor Grade
2023Open Access
Data from Modeling Renal Cell Carcinoma in Mice: <i>Bap1</i> and <i>Pbrm1</i> Inactivation Drive Tumor Grade
2023Open Access
Figure S1-S5 from Modulation of Mutant <i>Kras<sup>G12D</sup></i>-Driven Lung Tumorigenesis <i>In Vivo</i> by Gain or Loss of PCDH7 Function
2023Open Access
Supplementary Figure S2 from Modeling Renal Cell Carcinoma in Mice: <i>Bap1</i> and <i>Pbrm1</i> Inactivation Drive Tumor Grade
2023Open Access
Supplementary Figure Legends from Modeling Renal Cell Carcinoma in Mice: <i>Bap1</i> and <i>Pbrm1</i> Inactivation Drive Tumor Grade
2023Open Access
Data from Modulation of Mutant <i>Kras<sup>G12D</sup></i>-Driven Lung Tumorigenesis <i>In Vivo</i> by Gain or Loss of PCDH7 Function
2023Open Access
Supplementary Figure S2 from Modeling Renal Cell Carcinoma in Mice: <i>Bap1</i> and <i>Pbrm1</i> Inactivation Drive Tumor Grade
2023Open Access
Supplementary Figure S3 from Modeling Renal Cell Carcinoma in Mice: <i>Bap1</i> and <i>Pbrm1</i> Inactivation Drive Tumor Grade
2023Open Access
Acss2/HIF-2 signaling facilitates colon cancer growth and metastasis
PLoS ONE·2023· 19 citedOpen Access
page 1 of 19Next →

Frequent Co-authors

James A. Richardson(10), Jay D. Horton(10), Masashi Yanagisawa(8), Thomas C. Südhof(7), Iichiro Shimomura(7), S. Clay Williams(6), Ralph L. Brinster(6), Joseph L. Goldstein(5), Richard D. Palmiter(5), Joachim Herz(4), Joachim Herz(4), Hitoshi Shimano(4), J L Goldstein(4), David E. Clouthier(4), Joel K. Elmquist(3), Yaz Y. Kisanuki(3), Markus Missler(3), Michael S. Brown(3), Kiminori Hosoda(3), Yuriy K. Bashmakov(3)